Physician profile
Michael S George
NPI 1235110222
$13,369.97
in general payments reported to CMS, 2019-2025
24 companies · $1,392 in 2025
The $1,392 reported for 2025 was more than what 77% of Pediatric Orthopaedic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $723 · 2020: $2,475 · 2021: $7,709 · 2022: $223 · 2023: $217 · 2024: $631 · 2025: $1,392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,800 · Food and Beverage: $439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,800.00 |
| Food and Beverage | $439.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $6,955.58 | 2021 | |
| Integra Lifesciences Corporation | $2,115.43 | 2019-2020 | |
| Medacta USA, INC. | $2,050.06 | 2022-2025 | Mecta |
| Stryker Corporation | $873.28 | 2019-2025 | Tornier Perform Reversed Glenoid, Aequalis Perform |
| Pacira Therapeutics, INC. | $456.44 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $290.56 | 2019-2025 | Euflexxa |
| Catalyst Orthoscience | $130.41 | 2021 | |
| Depuy Synthes Sales INC. | $107.89 | 2019-2023 | Orthovisc |
| Zimmer Biomet Holdings, INC. | $45.09 | 2019 | |
| Globus Medical, INC. | $33.43 | 2025 | Senza |
| Davol INC. | $33.25 | 2020-2021 | |
| Painteq LLC | $30.54 | 2024 | Painteq |
| Abbott Laboratories | $27.93 | 2020-2021 | |
| Innovation Technologies INC | $27.60 | 2021 | |
| Horizon Therapeutics Plc | $25.95 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $25.90 | 2021 | |
| Wright Medical Technology, INC. | $23.18 | 2019 | |
| Fx Shoulder Solutions, INC | $22.96 | 2019 | |
| Vericel Corporation | $19.12 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $18.79 | 2021 | |
| Boston Scientific Corporation | $17.55 | 2021 | |
| Anika Therapeutics, INC. | $16.62 | 2021 | |
| Baudax Bio INC. | $11.79 | 2020 | |
| Arthrosurface Incorporated | $10.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.